A5059341542- Clostridium difficile and Clostridium perfringens research
- Helicobacter pylori-related gastroenterology studies
- Microscopic Colitis
- Clinical Nutrition and Gastroenterology
- Central Venous Catheters and Hemodialysis
- Esophageal and GI Pathology
- Dialysis and Renal Disease Management
- Nosocomial Infections in ICU
- Body Contouring and Surgery
- Nutrition and Health in Aging
- Gut microbiota and health
- Intestinal and Peritoneal Adhesions
- Systemic Sclerosis and Related Diseases
- Electrolyte and hormonal disorders
- Inflammatory Myopathies and Dermatomyositis
Aarhus University Hospital
2020-2023
BackgroundFaecal microbiota transplantation (FMT) is effective for recurrent Clostridioides difficile infection (CDI), but inconsistent effect rates and uncertain evidence levels have warranted caution. To clarify, we aimed to establish the of FMT CDI, updated across different delivery methods, treatment regimens, in comparison with standard antibiotics.MethodsIn this systematic review meta-analysis, searched PubMed, Scopus, Embase, Web Science, Clinical Key, Svemed+ literature published...
Patients with inflammatory bowel disease (IBD) are at an increased risk of developing Clostridioides difficile infection (CDI). Treatment CDI in patients IBD is challenging due to higher failure rates and concomitant activity.We performed a multicentre cohort study who received fecal microbiota transplantation (FMT) for recurrent (rCDI), further investigate factors that influence the clinical outcome course both rCDI IBD.This conducted five European FMT centres.Adult treated were studied....
Summary Background Faecal microbiota transplantation (FMT) is effective for recurrent Clostridioides difficile infection (rCDI), but its effect varies inexplicably. Aims To optimise the effectiveness of FMT rCDI and validate determinants Methods We conducted a cohort study, including all patients treated with between October 2018 June 2020. Statistical process control was used to evaluate impact prospective quality improvement on single treatments per 10–11 patients. Targeting an 80% effect,...
BackgroundIntestinal failure (IF) is defined by a need for intravenous (IV) supplementation. Patients may present with multiple morbidities, and IV treatments carry risk catheter-related complications. Few studies described patient characteristics clinical outcomes according to type of IF.MethodsWe consecutively included patients who were admitted newly established inpatient IF unit (IFU) from 2013 through 2017. We evaluated all patients' first admission. Outcomes classification, length...
Abstract Background Patients with intestinal failure (IF) are prone to hypophosphatemia and shifts in magnesium potassium levels. Although these often attributed refeeding syndrome (RFS), the incidence of electrolyte among patients IF is unknown. We evaluated occurrence other according functional pathophysiological classifications. Methods consecutively included all patients’ first admission an unit from 2013 2017. Electrolyte were defined as severe <0.6 mmol/L (mM) or any 2 below...
The cover image is based on the Original Article Donor, patient age and exposure to antibiotics are associated with outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study by Simon M. D. Baunwall et al., https://doi.org/10.1111/apt.17642 Image Credit: Nina Rågård